Achilles Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACHL and other ETFs, options, and stocks.

About ACHL

Achilles Therapeutics Plc is a biopharmaceutical company engages in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. 

CEO
Iraj Ali
CEOIraj Ali
Employees
252
Employees252
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2020
Founded2020
Employees
252
Employees252

ACHL Key Statistics

Market cap
92.15M
Market cap92.15M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
34.11K
Average volume34.11K
High today
$2.51
High today$2.51
Low today
$2.23
Low today$2.23
Open price
$2.37
Open price$2.37
Volume
23.30K
Volume23.30K
52 Week high
$9.00
52 Week high$9.00
52 Week low
$1.84
52 Week low$1.84

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
0%
Sell
16.7%

ACHL Earnings

-$8.38
-$5.59
-$2.79
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.